ImmunityBio (IBRX) Cash from Financing Activities (2014 - 2026)
ImmunityBio (IBRX) posted Cash from Financing Activities of $44.44 million for Q2 2026, down 74.3% from $172.81 million a year earlier and down 80.2% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Cash from Financing Activities (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at ImmunityBio was $496.78 million, up 68.8% year-over-year; for FY2025, it was $400.24 million, up 42.1% from FY2024.
- Annual Cash from Financing Activities shows a five-year compound annual growth rate of 21.6% (FY2020 to FY2025).
- In prior years, ImmunityBio's Cash from Financing Activities was $281.63 million in FY2024 (-49.6%), $558.34 million in FY2023 (+139.0%), $233.61 million in FY2022 (-53.8%) and $505.44 million in FY2021 (+235.5%).
- The Q2 2026 figure stands as the lowest quarterly Cash from Financing Activities since Q1 2025.
- On a year-over-year basis, Cash from Financing Activities increased in 1 of the last five quarters, with an average decline of 49.4%.
- The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q2 2024, with growth of 243.0%; the weakest was Q3 2024, with a decline of 93.4%.
- According to Business Quant data, Cash from Financing Activities for the three prior quarters was $223.93 million (Q1 2026), $54.89 million (Q4 2025) and $173.52 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | -2.51 Bn |
| 10 | ImmunityBio | 7.48 Bn | 6.24 Bn | 50.94 Mn | 44.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.44 Mn |
| Mar 31, 2026 | 223.93 Mn |
| Dec 31, 2025 | 54.89 Mn |
| Sep 30, 2025 | 173.52 Mn |
| Jun 30, 2025 | 172.81 Mn |
| Mar 31, 2025 | -982,000.00 |
| Dec 31, 2024 | 106.93 Mn |
| Sep 30, 2024 | 15.58 Mn |
| Jun 30, 2024 | 148.89 Mn |
| Mar 31, 2024 | 10.23 Mn |
| Dec 31, 2023 | 200.54 Mn |
| Sep 30, 2023 | 237.50 Mn |
| Jun 30, 2023 | 43.41 Mn |
| Mar 31, 2023 | 76.89 Mn |
| Dec 31, 2022 | 109.94 Mn |
| Sep 30, 2022 | 123.99 Mn |
| Jun 30, 2022 | -15,000.00 |
| Mar 31, 2022 | -298,000.00 |
| Dec 31, 2021 | 325.95 Mn |
| Sep 30, 2021 | 42.66 Mn |
API Access
ImmunityBio Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();